An anti-cancer compound developed at USA Health Mitchell Cancer Institute is showing promise in pre-clinical studies – one involving pancreatic cancer and the other involving breast cancer. The compound, MCI-715, was developed by Gary Piazza, Ph.D., and his lab team at the Drug Discovery Research Center at MCI.
About Mastin Internal Medicine
At Mastin Internal Medicine, we provide personalized preventative care and treatment to adult patients. Our physicians provide primary care and also specialize in a variety of health conditions including sickle cell disease, diabetes, various infectious diseases, kidney disease, hypertension, chronic pulmonary conditions, arthritis and sleep disorders.
Mastin Internal Medicine hours of operation are Monday through Friday, 8 a.m. to 5 p.m.
USA College of Medicine
Our physicians are also educators in the Department of Internal Medicine at the University of South Alabama College of Medicine. Visit the Department of Internal Medicine to learn about its academic mission, residency and fellowship programs.